Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
CTIC
There are no Buy or Sell transactions made by Matthew Perry since 11/21/2023
Holdings reported by Matthew Perry for Cti Biopharma Corp
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
0 |
|
$9.10 |
Jun 26, 2023 |
Direct |
|
|
| Stock Option (Right to Buy) |
0 |
|
|
Jun 26, 2023 |
Direct |
Common Stock |
|
Transactions reported by Matthew Perry for Cti Biopharma Corp
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.